Clene Inc. (CLNN) is the 203rd largest of 300 Pharmaceuticals companies by market capitalisation, at 45.69 Mn, behind Karyopharm Therapeutics Inc. at 46.45 Mn. The table below compares all 300 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JNJ | Johnson & Johnson | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 641.14 Bn | 30.48 | 0.00 Mn | 620.38 Bn |
| 2 | ABBV | AbbVie Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 451.04 Bn | 71.41 | 0.00 Mn | 444.47 Bn |
| 3 | MRK | Merck & Co., Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 357.43 Bn | 112.79 | 0.00 Mn | 350.29 Bn |
| 4 | NVS | Novartis Ag | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 266.73 Bn | 9.26 | 0.00 Mn | 259.04 Bn |
| 5 | PFE | Pfizer Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 157.52 Bn | 36.06 | 0.00 Mn | 145.82 Bn |
| 6 | SNY | Sanofi | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 52.14 Bn | 11.19 | 0.00 Mn | 44.76 Bn |
| 7 | RVMD | Revolution Medicines, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 42.88 Bn | -24.25 | — | 42.88 Bn |
| 8 | INCY | Incyte Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 24.70 Bn | 15.32 | 0.00 Mn | 20.16 Bn |
| 9 | UTHR | UNITED THERAPEUTICS Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 21.47 Bn | 16.38 | 0.00 Mn | 18.80 Bn |
| 10 | NBIX | Neurocrine Biosciences Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.82 Bn | 22.42 | 0.00 Mn | 15.43 Bn |
| 11 | JAZZ | Jazz Pharmaceuticals plc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.21 Bn | 16.17 | 0.00 Mn | 13.59 Bn |
| 12 | EXEL | Exelixis, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 14.39 Bn | 16.72 | 0.00 Mn | 13.55 Bn |
| 13 | CORT | Corcept Therapeutics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 12.10 Bn | 223.31 | 0.00 Mn | 11.80 Bn |
| 14 | KYMR | Kymera Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 11.49 Bn | -38.35 | 0.00 Mn | 10.80 Bn |
| 15 | AXSM | Axsome Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 10.94 Bn | -71.14 | 0.00 Mn | 10.62 Bn |
| 16 | NUVL | Nuvalent, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.75 Bn | -27.07 | — | 9.75 Bn |
| 17 | CYTK | Cytokinetics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.72 Bn | -13.26 | 0.00 Mn | 8.56 Bn |
| 18 | CRNX | Crinetics Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 8.99 Bn | -17.90 | 0.00 Mn | 8.99 Bn |
| 19 | GPCR | Structure Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 8.62 Bn | -45.80 | — | 8.62 Bn |
| 20 | ALKS | Alkermes plc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 7.69 Bn | 116.24 | 0.00 Mn | 7.03 Bn |
| 21 | TVTX | Travere Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.32 Bn | -145.30 | 0.00 Mn | 6.20 Bn |
| 22 | LQDA | Liquidia Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.03 Bn | 43.48 | 0.00 Mn | 5.74 Bn |
| 23 | BLTE | Belite Bio, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 5.88 Bn | 0.08 | — | 5.88 Bn |
| 24 | AMRN | Amarin Corp Plc\Uk | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 5.86 Bn | -216.02 | 0.00 Mn | 5.54 Bn |
| 25 | ACAD | Acadia Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.77 Bn | 12.53 | 0.00 Mn | 3.81 Bn |
| 26 | EWTX | Edgewise Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.61 Bn | -23.40 | — | 4.61 Bn |
| 27 | DFTX | Definium Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.18 Bn | -11.81 | — | 4.18 Bn |
| 28 | INDV | Indivior Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.11 Bn | 11.57 | 0.00 Mn | 3.89 Bn |
| 29 | MANE | Veradermics, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.98 Bn | -46.19 | — | 3.98 Bn |
| 30 | CPRX | CATALYST PHARMACEUTICALS, INC. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.85 Bn | 17.94 | 0.00 Mn | 3.09 Bn |
| 31 | ELVN | Enliven Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.72 Bn | -44.17 | — | 3.72 Bn |
| 32 | OGN | Organon & Co. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.58 Bn | 17.14 | 0.00 Mn | 2.45 Bn |
| 33 | TARS | Tarsus Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.52 Bn | -75.03 | 0.00 Mn | 3.07 Bn |
| 34 | NAMS | NewAmsterdam Pharma Co N.V. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.70 Bn | -10.39 | 0.00 Mn | 2.70 Bn |
| 35 | TAK | Takeda Pharmaceutical Co Ltd | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.59 Bn | 4.52 | 0.00 Mn | -3.20 Bn |
| 36 | TRVI | Trevi Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.49 Bn | -59.07 | — | 2.49 Bn |
| 37 | BEIGF | BeOne Medicines Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.48 Bn | 3.74 | 0.00 Mn | -2.62 Bn |
| 38 | MLYS | Mineralys Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.48 Bn | -7.10 | — | 2.48 Bn |
| 39 | SUPN | Supernus Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.42 Bn | -28.47 | 0.00 Mn | 2.05 Bn |
| 40 | HRMY | Harmony Biosciences Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.38 Bn | 13.34 | 0.00 Mn | 1.57 Bn |
| 41 | NUVB | Nuvation Bio Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.20 Bn | -20.32 | 0.00 Mn | 2.20 Bn |
| 42 | PVLA | Palvella Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.16 Bn | -40.73 | — | 1.85 Bn |
| 43 | AUPH | Aurinia Pharmaceuticals Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.09 Bn | 6.67 | 0.00 Mn | 1.65 Bn |
| 44 | ETON | Eton Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.60 Bn | 167.78 | 0.00 Mn | 1.58 Bn |
| 45 | INVA | Innoviva, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.51 Bn | 7.71 | 0.00 Mn | 0.94 Bn |
| 46 | LBRX | Lb Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.39 Bn | -23.05 | — | 1.39 Bn |
| 47 | HROW | Harrow, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.37 Bn | -40.84 | 0.00 Mn | 1.28 Bn |
| 48 | XERS | Xeris Biopharma Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.33 Bn | -77.22 | 0.00 Mn | 1.20 Bn |
| 49 | OPK | Opko Health, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.12 Bn | -29.60 | 0.00 Mn | 0.82 Bn |
| 50 | OLMA | Olema Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.12 Bn | -5.47 | — | 1.12 Bn |
| 51 | KURA | Kura Oncology, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.02 Bn | -4.31 | 0.00 Mn | 1.02 Bn |
| 52 | PCRX | Pacira BioSciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.00 Bn | 68.31 | 0.00 Mn | 0.75 Bn |
| 53 | DSGN | Design Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.92 Bn | -11.43 | — | 0.72 Bn |
| 54 | SGP | SpyGlass Pharma, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.91 Bn | -48.72 | — | 0.91 Bn |
| 55 | LXRX | Lexicon Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.88 Bn | -14.02 | 0.00 Mn | 0.69 Bn |
| 56 | VSTM | Verastem, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.76 Bn | -6.63 | 0.00 Mn | 0.63 Bn |
| 57 | COLL | Collegium Pharmaceutical, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.75 Bn | 15.57 | 0.00 Mn | 0.60 Bn |
| 58 | ZVRA | Zevra Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.71 Bn | 12.26 | 0.00 Mn | 0.49 Bn |
| 59 | PHAT | Phathom Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.70 Bn | -7.15 | 0.00 Mn | 0.52 Bn |
| 60 | IVEVF | Inventiva S.A. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.69 Bn | 7.19 | 0.00 Mn | 0.69 Bn |
| 61 | GYRE | Gyre Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.68 Bn | -36.78 | 0.00 Mn | 0.62 Bn |
| 62 | MPLT | MapLight Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.63 Bn | -3.12 | — | 0.63 Bn |
| 63 | CRMD | CorMedix Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.62 Bn | 4.96 | 0.00 Mn | 0.37 Bn |
| 64 | AQST | Aquestive Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.62 Bn | -7.95 | 0.00 Mn | 0.52 Bn |
| 65 | NVCT | Nuvectis Pharma, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.53 Bn | -17.55 | — | 0.53 Bn |
| 66 | EOLS | Evolus, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.52 Bn | -15.19 | 0.00 Mn | 0.48 Bn |
| 67 | OVID | Ovid Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.52 Bn | -15.08 | 0.00 Mn | 0.40 Bn |
| 68 | SPRY | ARS Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.50 Bn | -2.27 | 0.00 Mn | 0.36 Bn |
| 69 | PALI | Palisade Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.43 Bn | -12.07 | 0.00 Mn | 0.30 Bn |
| 70 | XFOR | X4 Pharmaceuticals, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.43 Bn | -4.72 | 0.00 Mn | 0.23 Bn |
| 71 | IKT | Inhibikase Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.41 Bn | -6.19 | — | 0.25 Bn |
| 72 | TTRX | Turn Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.40 Bn | -52.22 | — | 0.40 Bn |
| 73 | VTVT | vTv Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.40 Bn | -83.42 | 0.00 Mn | 0.40 Bn |
| 74 | SION | Sionna Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.35 Bn | -3.55 | — | 0.35 Bn |
| 75 | ACHV | Achieve Life Sciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | — | — | 0.32 Bn |
| 76 | EBS | Emergent BioSolutions Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.31 Bn | -1.73 | 0.00 Mn | 0.16 Bn |
| 77 | VNDA | Vanda Pharmaceuticals Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | -1.10 | 0.00 Mn | 0.13 Bn |
| 78 | IMRX | Immuneering Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | -5.04 | — | 0.30 Bn |
| 79 | FULC | Fulcrum Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -3.26 | — | 0.29 Bn |
| 80 | AKBA | Akebia Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.26 Bn | -8.62 | 0.00 Mn | 0.10 Bn |
| 81 | ZNTL | Zentalis Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.25 Bn | -1.82 | — | 0.25 Bn |
| 82 | CELG-RI | Bristol Myers Squibb Co | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.23 Bn | 0.03 | 0.00 Mn | -10.83 Bn |
| 83 | SIGA | Siga Technologies Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | — | — | 0.06 Bn |
| 84 | TNXP | Tonix Pharmaceuticals Holding Corp. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -1.28 | 0.00 Mn | 0.20 Bn |
| 85 | MCUJF | Medicure Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -38.89 | 0.00 Mn | 0.20 Bn |
| 86 | DERM | Journey Medical Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -53.39 | 0.00 Mn | 0.17 Bn |
| 87 | ACOG | Alpha Cognition Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -7.08 | 0.00 Mn | 0.15 Bn |
| 88 | NERV | Minerva Neurosciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -29.52 | — | 0.19 Bn |
| 89 | SLGL | Sol-Gel Technologies Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -17.71 | 0.00 Mn | 0.14 Bn |
| 90 | CRDL | Cardiol Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.17 Bn | -6.71 | — | 0.17 Bn |
| 91 | LONA | LeonaBio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.16 Bn | -1.33 | — | 0.11 Bn |
| 92 | LENZ | LENZ Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | -1.15 | 0.00 Mn | 0.15 Bn |
| 93 | MENS | Jyong Biotech Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | -46.69 | — | 0.15 Bn |
| 94 | BMEA | Biomea Fusion, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.12 Bn | -2.19 | — | 0.12 Bn |
| 95 | VANI | Vivani Medical, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.11 Bn | -4.01 | — | 0.09 Bn |
| 96 | AARD | Aardvark Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.11 Bn | -1.56 | — | 0.04 Bn |
| 97 | VRCA | Verrica Pharmaceuticals Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.11 Bn | -3.36 | 0.00 Mn | 0.09 Bn |
| 98 | CPIX | Cumberland Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -8.96 | 0.00 Mn | 0.09 Bn |
| 99 | NTHI | Neonc Technologies Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -2.02 | — | 0.09 Bn |
| 100 | TENX | Tenax Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -1.37 | — | 0.09 Bn |
| 101 | CGTX | Cognition Therapeutics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -2.42 | — | 0.09 Bn |
| 102 | MNOV | Medicinova Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | -7.43 | 0.00 Mn | 0.08 Bn |
| 103 | PTHS | Pelthos Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | -0.72 | 0.00 Mn | 0.06 Bn |
| 104 | PMVP | PMV Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | -1.26 | — | 0.00 Bn |
| 105 | RGC | Regencell Bioscience Holdings Ltd | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | — | — | 0.07 Bn |
| 106 | PLRX | Pliant Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -0.76 | — | 0.07 Bn |
| 107 | BOLD | Boundless Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | -1.00 | — | 0.06 Bn |
| 108 | VERU | Veru Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | 114.15 | — | 0.03 Bn |
| 109 | KPTI | Karyopharm Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.23 | 0.00 Mn | -0.02 Bn |
| 110 | CLNN | Clene Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -1.37 | 0.00 Mn | 0.05 Bn |
| 111 | GOSS | Gossamer Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.27 | 0.00 Mn | -0.01 Bn |
| 112 | ANVS | Annovis Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.92 | — | 0.04 Bn |
| 113 | APRE | Aprea Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -3.41 | — | 0.04 Bn |
| 114 | IXHL | Incannex Healthcare Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.82 | — | 0.04 Bn |
| 115 | GRCE | Grace Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -1.98 | — | 0.04 Bn |
| 116 | SCLX | Scilex Holding Co | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.08 | 0.00 Mn | -0.08 Bn |
| 117 | UG | United Guardian Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | 14.62 | 0.00 Mn | 0.02 Bn |
| 118 | BYSI | BeyondSpring Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -3.73 | — | 0.03 Bn |
| 119 | CPHI | China Pharma Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -7.01 | 0.00 Mn | 0.03 Bn |
| 120 | ACTU | Actuate Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -1.34 | — | 0.03 Bn |
| 121 | NSRX | Nasus Pharma Ltd | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -5.64 | — | 0.03 Bn |
| 122 | CRVO | CervoMed Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -0.84 | 0.00 Mn | 0.03 Bn |
| 123 | YARW | Yarrow Bioscience, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.18 | 0.00 Mn | 0.00 Bn |
| 124 | TXMD | TherapeuticsMD, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -129.51 | 0.00 Mn | 0.01 Bn |
| 125 | AYTU | Aytu Biopharma, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.70 | 0.00 Mn | -0.01 Bn |
| 126 | ATOS | Atossa Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.69 | — | 0.02 Bn |
| 127 | ALLR | Allarity Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.64 | 0.00 Mn | 0.02 Bn |
| 128 | BFRI | Biofrontera Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -4.02 | 0.00 Mn | 0.01 Bn |
| 129 | MIRA | Mira Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.56 | — | 0.01 Bn |
| 130 | TVRD | Tvardi Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.65 | — | 0.02 Bn |
| 131 | KPRX | Kiora Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.45 | — | 0.02 Bn |
| 132 | CTXR | Citius Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.33 | 0.00 Mn | 0.02 Bn |
| 133 | ANEB | Anebulo Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.64 | — | 0.01 Bn |
| 134 | INTI | Inhibitor Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -3.67 | — | 0.01 Bn |
| 135 | CALC | CalciMedica, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.35 | 0.00 Mn | -0.01 Bn |
| 136 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.80 | — | 0.01 Bn |
| 137 | CURX | Curanex Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.82 | — | 0.00 Bn |
| 138 | ACXP | Acurx Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.79 | — | 0.01 Bn |
| 139 | ADXN | Addex Therapeutics Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | 0.04 | — | 0.01 Bn |
| 140 | TRAW | Traws Pharma, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.34 | — | 0.00 Bn |
| 141 | PULM | Pulmatrix, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.31 | — | 0.01 Bn |
| 142 | PCSA | Processa Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.38 | — | 0.01 Bn |
| 143 | TCRT | Alaunos Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.93 | 0.00 Mn | 0.00 Bn |
| 144 | BICX | BioCorRx Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.64 | 0.00 Mn | 0.00 Bn |
| 145 | CVKD | Cadrenal Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.29 | — | 0.00 Bn |
| 146 | CASIF | CASI Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.02 | 0.00 Mn | 0.00 Bn |
| 147 | OGEN | Oragenics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.22 | — | 0.00 Bn |
| 148 | CANF | Can-Fite BioPharma Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.24 | 0.00 Mn | 0.00 Bn |
| 149 | UPC | Universe Pharmaceuticals INC | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | -1,490.23 Bn |
| 150 | ENSC | Ensysce Biosciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | 0.00 Bn |
| 151 | MTNB | Matinas BioPharma Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.18 | — | 0.00 Bn |
| 152 | SKVI | Skinvisible, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.05 | 0.00 Mn | 0.00 Bn |
| 153 | SPRC | SciSparc Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.05 | 0.00 Mn | 0.00 Bn |
| 154 | NCEL | NewcelX Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.06 | — | 0.00 Bn |
| 155 | GLMD | Galmed Pharmaceuticals Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | 0.00 Bn |
| 156 | JAGX | Jaguar Health, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | 0.00 | 0.00 Mn | -0.01 Bn |
| 157 | GCAN | Trafalgar International, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.77 | — | 0.00 Bn |
| 158 | CDT | CDT Equity Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.01 | — | 0.00 Bn |
| 159 | CINGW | Cingulate Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | 0.00 | — | 0.00 Bn |
| 160 | SXTC | China SXT Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | 0.00 | 0.00 Mn | -0.03 Bn |
| 161 | CMND | Clearmind Medicine Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | 0.00 | — | -0.01 Bn |
| 162 | PG | PROCTER & GAMBLE Co | secondary | S-10 | Household and Personal Products | SG-05 | 333.49 Bn | 20.66 | 0.00 Mn | 323.54 Bn |
| 163 | GILD | Gilead Sciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 179.97 Bn | -62.17 | 0.00 Mn | 176.79 Bn |
| 164 | VRTX | Vertex Pharmaceuticals Inc / Ma | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 130.57 Bn | 29.64 | 0.00 Mn | 122.72 Bn |
| 165 | CL | Colgate Palmolive Co | secondary | S-11 | Household and Personal Products | SG-05 | 70.23 Bn | 32.50 | 0.00 Mn | 68.86 Bn |
| 166 | TEVA | Teva Pharmaceutical Industries Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 42.33 Bn | 60.82 | 0.00 Mn | 38.68 Bn |
| 167 | ADM | Archer-Daniels-Midland Co | secondary | S-07 | Agribusiness | SG-03 | 42.12 Bn | 23.67 | 0.00 Mn | 32.54 Bn |
| 168 | KVUE | Kenvue Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 34.13 Bn | 20.58 | 0.00 Mn | 33.02 Bn |
| 169 | ALC | Alcon Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 32.83 Bn | 51.06 | 0.00 Mn | 31.37 Bn |
| 170 | KMB | Kimberly Clark Corp | secondary | S-11 | Household and Personal Products | SG-05 | 32.73 Bn | 18.43 | 0.00 Mn | 31.77 Bn |
| 171 | ROIV | Roivant Sciences Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 29.49 Bn | -19.87 | 0.00 Mn | 29.49 Bn |
| 172 | GEHC | GE HealthCare Technologies Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 29.10 Bn | 14.19 | 0.00 Mn | 26.99 Bn |
| 173 | INSM | INSMED Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 27.67 Bn | -31.61 | 0.00 Mn | 26.51 Bn |
| 174 | CHD | Church & Dwight Co Inc /De/ | secondary | S-10 | Household and Personal Products | SG-05 | 22.22 Bn | 29.83 | 0.00 Mn | 21.96 Bn |
| 175 | VTRS | Viatris Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 19.05 Bn | -46.38 | 0.00 Mn | 18.16 Bn |
| 176 | BWXT | BWX Technologies, Inc. | secondary | I-39 | Clean Energy Equipment | IG-10 | 13.96 Bn | 39.20 | 0.00 Mn | 13.35 Bn |
| 177 | CLX | Clorox Co /De/ | secondary | S-10 | Household and Personal Products | SG-05 | 10.80 Bn | 17.97 | 0.00 Mn | 10.66 Bn |
| 178 | GKOS | GLAUKOS Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.03 Bn | -63.68 | 0.00 Mn | 9.92 Bn |
| 179 | PRAX | Praxis Precision Medicines, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 9.87 Bn | -25.87 | — | 9.11 Bn |
| 180 | CHWY | Chewy, Inc. | secondary | S-04 | Branded Foods | SG-02 | 8.74 Bn | 34.23 | 0.00 Mn | 8.22 Bn |
| 181 | CELH | Celsius Holdings, Inc. | secondary | S-03 | Beverages | SG-01 | 6.79 Bn | 113.17 | 0.00 Mn | 6.16 Bn |
| 182 | BLRX | BioLineRx Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.33 Bn | -707.29 | 0.00 Mn | 6.33 Bn |
| 183 | BLCO | Bausch & Lomb Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.28 Bn | -38.53 | 0.00 Mn | 5.90 Bn |
| 184 | AMRX | Amneal Pharmaceuticals, Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 5.38 Bn | 24.99 | 0.00 Mn | 5.25 Bn |
| 185 | ERAS | Erasca, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.97 Bn | -17.31 | — | 4.97 Bn |
| 186 | FMCQF | Fresenius Medical Care AG | secondary | H-14 | Healthcare Providers | HG-04 | 4.79 Bn | 4.57 | 0.00 Mn | 4.09 Bn |
| 187 | DNLI | Denali Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.01 Bn | -7.84 | 0.00 Mn | 4.01 Bn |
| 188 | BBWI | Bath & Body Works, Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 3.77 Bn | 5.70 | 0.00 Mn | 2.98 Bn |
| 189 | IPAR | Interparfums Inc | secondary | S-12 | Household and Personal Products | SG-05 | 3.53 Bn | 17.23 | 0.00 Mn | 3.32 Bn |
| 190 | RCUS | Arcus Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.27 Bn | -7.11 | 0.00 Mn | 2.57 Bn |
| 191 | NRIX | Nurix Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.87 Bn | -8.41 | 0.00 Mn | 2.43 Bn |
| 192 | IMNM | Immunome Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.83 Bn | -10.46 | 0.00 Mn | 2.31 Bn |
| 193 | ZLAB | Zai Lab Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.69 Bn | -14.30 | 0.00 Mn | 1.98 Bn |
| 194 | WDFC | Wd 40 Co | secondary | S-10 | Household and Personal Products | SG-05 | 2.67 Bn | 29.96 | 0.00 Mn | 2.61 Bn |
| 195 | CURLF | Curaleaf Holdings, Inc. | secondary | S-09 | Tobacco and Cannabis | SG-04 | 2.58 Bn | -21.76 | 0.00 Mn | 2.48 Bn |
| 196 | SLS | SELLAS Life Sciences Group, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.55 Bn | -78.59 | — | 2.55 Bn |
| 197 | BHC | Bausch Health Companies Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 2.27 Bn | -2.08 | 0.00 Mn | 0.44 Bn |
| 198 | PBH | Prestige Consumer Healthcare Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 2.27 Bn | — | — | 2.21 Bn |
| 199 | BCRX | Biocryst Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.11 Bn | -5.47 | 0.00 Mn | 1.75 Bn |
| 200 | SPB | Spectrum Brands Holdings, Inc. | secondary | S-04 | Branded Foods | SG-02 | 1.98 Bn | 23.35 | 0.00 Mn | 1.72 Bn |
| 201 | ZBIO | Zenas BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.95 Bn | -4.68 | 0.00 Mn | 1.95 Bn |
| 202 | BHVN | Biohaven Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.92 Bn | -3.28 | — | 1.66 Bn |
| 203 | PRGO | PERRIGO Co plc | secondary | S-11 | Household and Personal Products | SG-05 | 1.89 Bn | -1.09 | 0.00 Mn | 1.49 Bn |
| 204 | ANIP | Ani Pharmaceuticals Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.51 Bn | 14.00 | 0.00 Mn | 1.15 Bn |
| 205 | AAPG | Ascentage Pharma Group International | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.49 Bn | -9.11 | 0.00 Mn | 1.21 Bn |
| 206 | RARE | Ultragenyx Pharmaceutical Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.47 Bn | -3.18 | 0.00 Mn | 1.18 Bn |
| 207 | NMAX | Newsmax Inc. | secondary | C-05 | Advertising and Media | CG-02 | 1.41 Bn | -17.79 | 0.00 Mn | 1.37 Bn |
| 208 | AVBP | ArriVent BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.37 Bn | -8.37 | — | 1.37 Bn |
| 209 | OMER | Omeros Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.34 Bn | 78.67 | 0.00 Mn | 1.34 Bn |
| 210 | HLF | Herbalife Ltd. | secondary | S-11 | Household and Personal Products | SG-05 | 1.28 Bn | 5.02 | 0.00 Mn | 0.91 Bn |
| 211 | EPC | EDGEWELL PERSONAL CARE Co | secondary | S-11 | Household and Personal Products | SG-05 | 1.24 Bn | -17.86 | 0.00 Mn | 0.84 Bn |
| 212 | CRVS | Corvus Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.19 Bn | -24.95 | — | 0.98 Bn |
| 213 | RAJAF | TFA Therapeutics, Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 1.02 Bn | — | 0.00 Mn | 1.02 Bn |
| 214 | MNPR | Monopar Therapeutics | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.94 Bn | -67.71 | — | 0.89 Bn |
| 215 | ODD | Oddity Tech Ltd | secondary | S-12 | Household and Personal Products | SG-05 | 0.92 Bn | 12.59 | 0.00 Mn | 0.62 Bn |
| 216 | ACRS | Aclaris Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.79 Bn | -9.87 | 0.00 Mn | 0.79 Bn |
| 217 | EVOH | EvoAir Holdings Inc. | secondary | I-14 | Construction Products | IG-03 | 0.63 Bn | -56.89 | 0.00 Mn | 0.62 Bn |
| 218 | HELE | Helen Of Troy Ltd | secondary | D-06 | Household Durables | DG-02 | 0.62 Bn | -1.49 | 0.00 Mn | 0.59 Bn |
| 219 | OCS | Oculis Holding AG | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.59 Bn | -338,119.55 | — | 0.59 Bn |
| 220 | HNST | Honest Company, Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 0.59 Bn | -48.24 | 0.00 Mn | 0.48 Bn |
| 221 | IRD | Opus Genetics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.58 Bn | -5.94 | 0.00 Mn | 0.49 Bn |
| 222 | BWMX | Betterware De Mexico, S.A.P.I. De C.V | secondary | S-12 | Household and Personal Products | SG-05 | 0.58 Bn | 10.17 | 0.00 Mn | 0.55 Bn |
| 223 | DCTH | Delcath Systems, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.57 Bn | 1,147.23 | 0.00 Mn | 0.47 Bn |
| 224 | ANL | Adlai Nortye Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.49 Bn | -10.27 | 0.00 Mn | 0.26 Bn |
| 225 | PRLD | Prelude Therapeutics Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.46 Bn | -6.80 | 0.00 Mn | 0.18 Bn |
| 226 | EVMN | Evommune, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.38 Bn | -3.99 | 0.00 Mn | 0.18 Bn |
| 227 | PRE | Prenetics Global Ltd | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.33 Bn | -7.03 | 0.00 Mn | 0.27 Bn |
| 228 | SWKHL | SWK Holdings Corp | secondary | F-06 | Lending and Credit | FG-02 | 0.31 Bn | -332.82 | 0.00 Mn | 0.27 Bn |
| 229 | USNA | Usana Health Sciences Inc | secondary | S-11 | Household and Personal Products | SG-05 | 0.27 Bn | -9.37 | 0.00 Mn | 0.11 Bn |
| 230 | BFNH | Bioforce Nanosciences Holdings, Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 0.25 Bn | -2,456.25 | — | 0.25 Bn |
| 231 | NATR | Natures Sunshine Products Inc | secondary | S-11 | Household and Personal Products | SG-05 | 0.24 Bn | 12.94 | 0.00 Mn | 0.16 Bn |
| 232 | NAGE | Niagen Bioscience, Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 0.24 Bn | 15.08 | 0.00 Mn | 0.17 Bn |
| 233 | NUS | Nu Skin Enterprises, Inc. | secondary | S-12 | Household and Personal Products | SG-05 | 0.24 Bn | -1.07 | 0.00 Mn | 0.04 Bn |
| 234 | FTH | Faeth Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | -1.12 | — | 0.22 Bn |
| 235 | PTNM | Pitanium Ltd | secondary | S-12 | Household and Personal Products | SG-05 | 0.21 Bn | -63.51 | 0.00 Mn | -2.70 Bn |
| 236 | WALD | Waldencast plc | secondary | S-12 | Household and Personal Products | SG-05 | 0.15 Bn | -1.80 | 0.00 Mn | 0.12 Bn |
| 237 | NWOEF | New Oriental Education & Technology Group Inc. | secondary | D-28 | Consumer Services | DG-09 | 0.14 Bn | 0.17 | 0.00 Mn | -2.26 Bn |
| 238 | TNYA | Tenaya Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | -1.37 | 0.00 Mn | 0.14 Bn |
| 239 | IFRX | InflaRx N.V. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | 0.00 | 0.00 Mn | -0.04 Bn |
| 240 | MED | Medifast Inc | secondary | S-11 | Household and Personal Products | SG-05 | 0.13 Bn | -5.25 | 0.00 Mn | -0.04 Bn |
| 241 | SPRB | Spruce Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | -2.74 | — | 0.13 Bn |
| 242 | FTLF | Fitlife Brands, Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 0.09 Bn | 13.85 | 0.00 Mn | 0.09 Bn |
| 243 | PYPD | PolyPid Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | 2.69 | — | 0.08 Bn |
| 244 | FBIO | Fortress Biotech, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | 9.82 | 0.00 Mn | -0.11 Bn |
| 245 | LFVN | Lifevantage Corp | secondary | S-11 | Household and Personal Products | SG-05 | 0.08 Bn | 16.43 | 0.00 Mn | 0.06 Bn |
| 246 | AIFC | AI Financial Corp | secondary | T-54 | Fintech | TG-09 | 0.07 Bn | -0.08 | 0.00 Mn | 0.06 Bn |
| 247 | GWLL | Goldenwell Biotech, Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 0.07 Bn | -574.97 | 1.26 Mn | 0.07 Bn |
| 248 | UPXI | Upexi, Inc. | secondary | T-59 | Fintech | TG-09 | 0.07 Bn | -0.27 | 0.00 Mn | 0.06 Bn |
| 249 | CWBHF | Charlotte's Web Holdings, Inc. | secondary | S-09 | Tobacco and Cannabis | SG-04 | 0.06 Bn | -1.84 | 0.00 Mn | 0.05 Bn |
| 250 | HAIN | Hain Celestial Group Inc | secondary | S-04 | Branded Foods | SG-02 | 0.06 Bn | -0.15 | 0.00 Mn | 0.01 Bn |
| 251 | LEEEF | Leef Brands Inc. | secondary | S-09 | Tobacco and Cannabis | SG-04 | 0.05 Bn | -11.75 | 0.00 Mn | 0.05 Bn |
| 252 | IBO | Impact Biomedical Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -2.64 | 0.00 Mn | 0.05 Bn |
| 253 | ABLV | Able View Global Inc. | secondary | S-12 | Household and Personal Products | SG-05 | 0.05 Bn | 13.49 | 0.00 Mn | 0.04 Bn |
| 254 | PTN | Palatin Technologies Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -7.50 | 0.00 Mn | 0.05 Bn |
| 255 | LSF | Laird Superfood, Inc. | secondary | S-03 | Beverages | SG-01 | 0.04 Bn | -8.01 | 0.00 Mn | 0.02 Bn |
| 256 | GROV | Grove Collaborative Holdings, Inc. | secondary | S-10 | Household and Personal Products | SG-05 | 0.04 Bn | -5.34 | 0.00 Mn | 0.03 Bn |
| 257 | BODI | Beachbody Company, Inc. | secondary | T-48 | Internet Platforms | TG-08 | 0.04 Bn | — | — | 0.00 Bn |
| 258 | BTMD | biote Corp. | secondary | H-14 | Healthcare Providers | HG-04 | 0.04 Bn | 5.75 | 0.00 Mn | 0.03 Bn |
| 259 | PETS | Petmed Express Inc | secondary | S-14 | Staples Retail | SG-06 | 0.04 Bn | -1.25 | 0.00 Mn | 0.02 Bn |
| 260 | APLM | Apollomics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -3.72 | 0.00 Mn | 0.03 Bn |
| 261 | BHST | Bioharvest Sciences Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -3.12 | 0.00 Mn | 0.02 Bn |
| 262 | BETRF | BetterLife Pharma Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -21.49 | — | 0.03 Bn |
| 263 | KAPA | Kairos Pharma, LTD. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -6.19 | 0.00 Mn | 0.03 Bn |
| 264 | HAFG | Holistic Asset Finance Group Co., Ltd. | secondary | C-04 | Advertising and Media | CG-02 | 0.03 Bn | -269.75 | 0.00 Mn | 0.03 Bn |
| 265 | RAPH | Raphael Pharmaceutical Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -23.02 | — | 0.03 Bn |
| 266 | IGC | IGC Pharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -12.26 | 0.00 Mn | 0.03 Bn |
| 267 | ANKM | Ankam, Inc. | secondary | T-18 | Business Applications | TG-03 | 0.03 Bn | -83.84 | 0.00 Mn | 0.03 Bn |
| 268 | ABVC | Abvc Biopharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -3.61 | — | 0.03 Bn |
| 269 | INVU | Investview, Inc. | secondary | T-64 | Technology Services | TG-11 | 0.02 Bn | -1.82 | 0.00 Mn | 0.02 Bn |
| 270 | STCB | Starco Brands, Inc. | secondary | S-04 | Branded Foods | SG-02 | 0.02 Bn | -0.99 | 0.00 Mn | 0.02 Bn |
| 271 | CFOO | China Foods Holdings Ltd. | secondary | S-11 | Household and Personal Products | SG-05 | 0.02 Bn | -75.98 | 0.00 Mn | 0.02 Bn |
| 272 | MTEX | Mannatech Inc | secondary | S-11 | Household and Personal Products | SG-05 | 0.02 Bn | -1.09 | 0.00 Mn | 0.01 Bn |
| 273 | MDBH | MDB Capital Holdings, LLC | secondary | F-17 | Capital Markets | FG-05 | 0.02 Bn | -1.25 | — | 0.01 Bn |
| 274 | LDDD | Longduoduo Co Ltd | secondary | H-14 | Healthcare Providers | HG-04 | 0.02 Bn | -35.14 | 0.00 Mn | 0.01 Bn |
| 275 | DSY | Big Tree Cloud Holdings Ltd | secondary | S-11 | Household and Personal Products | SG-05 | 0.02 Bn | — | — | 0.01 Bn |
| 276 | HYEX | Healthy Extracts Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 0.01 Bn | -16.64 | 0.00 Mn | 0.01 Bn |
| 277 | QCLS | Q/C Technologies, Inc. | secondary | T-01 | Semiconductors | TG-01 | 0.01 Bn | -2.05 | — | 0.01 Bn |
| 278 | NHTC | Natural Health Trends Corp | secondary | S-11 | Household and Personal Products | SG-05 | 0.01 Bn | -8.29 | 0.00 Mn | -0.01 Bn |
| 279 | RKTO | Rocket One Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.02 | — | 0.01 Bn |
| 280 | DOGZ | Dogness (International) Corp | secondary | S-04 | Branded Foods | SG-02 | 0.01 Bn | — | — | 0.01 Bn |
| 281 | ADIA | Adia Nutrition, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -75.51 | 0.00 Mn | 0.01 Bn |
| 282 | VNOV | VitaNova Life Sciences Corp | secondary | I-26 | Business Services | IG-06 | 0.01 Bn | -308.43 | 0.00 Mn | 0.01 Bn |
| 283 | BNKK | Bonk, Inc. | secondary | S-03 | Beverages | SG-01 | 0.01 Bn | -0.35 | 0.00 Mn | 0.01 Bn |
| 284 | DARE | Dare Bioscience, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.89 | 0.00 Mn | 0.00 Bn |
| 285 | CABR | Caring Brands, Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 0.01 Bn | -1.06 | — | 0.01 Bn |
| 286 | BIOE | Bio Essence Corp | secondary | S-11 | Household and Personal Products | SG-05 | 0.01 Bn | 6.04 | 0.00 Mn | 0.01 Bn |
| 287 | IMRN | Immuron Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -2.71 | 0.00 Mn | 0.00 Bn |
| 288 | ASBP | Aspire Biopharma Holdings, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.61 | 0.00 Mn | 0.00 Bn |
| 289 | CUPR | Cuprina Holdings (Cayman) LTD | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | -1.73 | 0.00 Mn | 0.00 Bn |
| 290 | ATER | Aterian, Inc. | secondary | D-32 | Retail | DG-10 | 0.01 Bn | -0.61 | 0.00 Mn | 0.00 Bn |
| 291 | GXAI | Gaxos.Ai Inc. | secondary | T-40 | Infrastructure Software | TG-06 | 0.01 Bn | -1.60 | 0.00 Mn | 0.01 Bn |
| 292 | VYND | Vynleads, Inc. | secondary | T-27 | Vertical Software | TG-05 | 0.01 Bn | -27.04 | — | 0.01 Bn |
| 293 | GELS | Gelteq Ltd | secondary | H-12 | Pharma Services | HG-03 | 0.01 Bn | — | — | 0.01 Bn |
| 294 | HCWC | Healthy Choice Wellness Corp. | secondary | S-13 | Staples Retail | SG-06 | 0.01 Bn | -0.77 | 0.00 Mn | 0.01 Bn |
| 295 | TKLF | Tokyo Lifestyle Co., Ltd. | secondary | D-36 | Retail | DG-10 | 0.01 Bn | 11.57 | 0.00 Mn | 0.01 Bn |
| 296 | AIXN | AiXin Life International, Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 0.01 Bn | -3.18 | 0.00 Mn | 0.01 Bn |
| 297 | DQWS | DSwiss Inc | secondary | S-11 | Household and Personal Products | SG-05 | 0.01 Bn | -27.32 | 0.00 Mn | 0.01 Bn |
| 298 | ALZN | Alzamend Neuro, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.65 | — | 0.01 Bn |
| 299 | INM | InMed Pharmaceuticals Inc. | secondary | M-02 | Chemicals | MG-01 | 0.01 Bn | -0.66 | — | 0.00 Bn |
| 300 | YCBD | cbdMD, Inc. | secondary | S-09 | Tobacco and Cannabis | SG-04 | 0.01 Bn | -1.47 | 0.00 Mn | 0.00 Bn |